42 Chapter | 2 Comparative Medical Genetics mice following AAV-mediated neonatal gene transfer . Gene Ther. 8 , 1291 – 1298 . Daly , T. M. , Okuyama , T. , Vogler , C. , Haskins , M. E. , Muzyczka , N. , and Sands , M. S. ( 1999 a ). Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged betaglucuronidase expression in situ and correction <strong>of</strong> liver pathology in mucopolysaccharidosis type VII mice . Hum. Gene Ther. 10 , 85 – 94 . Daly , T. M. , Vogler , C. , Levy , B. , Haskins , M. E. , and Sands , M. S. ( 1999 b ). Neonatal gene transfer leads to widespread correction <strong>of</strong> pathology in a murine model <strong>of</strong> lysosomal storage disease . Proc. Natl. Acad. Sci. USA 96 , 2296 – 2300 . Donsante , A. , Vogler , C. , Muzyczka , N. , Crawford , J. M. , Barker , J. , Flotte , T. , Campbell-Thompson , M. , Daly , T. , and Sands , M. S. ( 2001 ). Observed incidence <strong>of</strong> tumorigenesis in long-term rodent studies <strong>of</strong> rAAV vectors . Gene Ther. 8 , 1343 – 1346 . Dunbar , C. E. , Kohn , D. B. , Schiffmann , R. , Barton , N. W. , Nolta , J. A. , Esplin , J. A. , Pensiero , M. , Long , Z. , Lockey , C. , Emmons , R. V. , Csik , S. , Leitman , S. , Krebs , C. B. , Carter , C. , Brady , R. O. , and Karlsson , S. ( 1998 ). Retroviral transfer <strong>of</strong> the glucocerebrosidase gene into CD34 cells from patients with Gaucher disease: in vivo detection <strong>of</strong> transduced cells without myeloablation . Hum. Gene Ther. 9 , 2629 – 2640 . Elliger , S. S. , Elliger , C. A. , Aguilar , C. P. , Raju , N. R. , and Watson , G. L. ( 1999 ). Elimination <strong>of</strong> lysosomal storage in brains <strong>of</strong> MPS VII mice treated by intrathecal administration <strong>of</strong> an adeno-associated virus vector . Gene Ther. 6 ( 6 ) , 1175 – 1178 . Ellinwood , N. M. , Vite , C. H. , and Haskins , M. E. ( 2004 ). Gene therapy for lysosomal storage diseases: the lessons and promise <strong>of</strong> animal models . J. Gene Med. 6 , 481 – 506 . Fields , B. N. , and Knipe , D. M. ( 1986 ). “ Fundamental Virology . ” Raven Press , New York . Follenzi , A. , Sabatino , G. , Lombardo , A. , Boccaccio , C. , and Naldini , L. ( 2002 ). Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors . Hum. Gene Ther. 13 , 243 – 260 . Foureman , P. , Whiteley , M. , and Giger , U. ( 2002 ). Canine leukocyte adhesion deficiency: presence <strong>of</strong> the Cys36Ser beta 2 integrin mutation in an affected Irish setter cross-bred dog and in Irish Red and White setters in the US . J. Vet. Intern. Med. 16 , 518 – 521 . Fujii , J. , Otsu , K. , Zorzato , F. , de Leon , S. , Khanna , V. K. , Weiler , J. E. , O’Brien , P. J. , and MacLennan , D. H. ( 1991 ). Identification <strong>of</strong> a mutation in porcine ryanodine receptor associated with malignant hyperthermia . Science 253 ( 5018 ) , 448 – 451 . Fyfe , J. C. , Madsen , M. , Hojrup , P. , Christensen , E. I. , Tanner , S. M. , de la Chapelle , A. , He , Q. , and Moestrup , S. K. ( 2004 ). The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex <strong>of</strong> cubilin and amnionless . Blood 103 , 1573 – 1579 . Gao , C. , Sands , M. S. , Haskins , M. E. , and Ponder , K. P. ( 2000 ). Delivery <strong>of</strong> a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice . Mol. Ther. 2 , 233 – 244 . Gao , G. , Vandenberghe , L. H. , and Wilson , J. M. ( 2005 ). New recombinant serotypes <strong>of</strong> AAV vectors . Curr. Gene Ther. 5 , 285 – 297 . Giger , U. Hereditary ethrocyte disorders . In “ Kirk’s Current Veterinary Therapy XIV ( J. D. Bonagura , Ed.) , Saunders , Philadelphia , in press. Giger , U. , Harvey , J. W. , Yamaguchi , R. A. , McNulty , P. K. , Chiapella , A. , and Beutler , E. ( 1985 ). Inherited phosph<strong>of</strong>ructokinase deficiency in dogs with hyperventilation-induced hemolysis: increased in vitro and in vivo alkaline fragility <strong>of</strong> erythrocytes . Blood 65 , 345 – 351 . Giger , U. , and Jezyk , P. F. ( 1992 ). Diagnosis <strong>of</strong> inherited diseases in small animals . In “ Current Veterinary Therapy XI Small Animal Practice ” ( R. W. Kirk and J. D. Bonagura , Eds.) , pp. 18 – 22 . Saunders , Philadelphia . Giger , U. , Sargan , D. R. , and McNiel , E. A. (2006 ). Breed-specific hereditary diseases and genetic screening . In “ The Dog and Its Genome ” ( E. A. Ostrander , U. Giger , and K. Lindblad-Toh , Eds.) pp. 249–289. Cold Spring Harbor Laboratory Press , New York . Griffey , M. , Macauley , S. L. , Ogilvie , J. M. , and Sands , M. S. ( 2005 ). AAV2-mediated ocular gene therapy for infantile neuronal ceroid lip<strong>of</strong>uscinosis . Mol. Ther. 12 , 413 – 421 . Hacein-Bey-Abina , S. , von Kalle , C. , Schmidt , M. , Le Deist , F. , Wulffraat , N. , McIntyre , E. , Radford , I. , Villeval , J. L. , Fraser , C. C. , Cavazzana-Calvo , M. , and Fischer , A. ( 2003 ). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency . N. Engl. J. Med. 348 , 255 – 256 . Hartung , S. D. , Frandsen , J. L. , Pan , D. , Koniar , B. L. , Graupman , P. , Gunther , R. , Low , W. C. , Whitley , C. B. , and McIvor , R. S. ( 2004 ). Correction <strong>of</strong> metabolic, crani<strong>of</strong>acial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene . Mol. Ther. 9 , 866 – 875 . Haskell , R. E. , Hughes , S. M. , Chiorini , J. A. , Alisky , J. M. , and Davidson , B. L. ( 2003 ). Viral-mediated delivery <strong>of</strong> the late-infantile neuronal ceroid lip<strong>of</strong>uscinosis gene, TPP-I to the mouse central nervous system . Gene Ther. 10 ( 1 ) , 34 – 42 . Haskins, M. E., and Giger, U. Lysosomal storage diseases. In “<strong>Biochemistry</strong> in <strong>Domestic</strong> <strong>Animals</strong> ” (J. Kaneko, Ed.), Elsevier Academic Press, Boston, in press. He , Q. , Madsen , M. , Kilkenney , A. , Gregory , B. , Christensen , E. I. , Vorum , H. , Hojrup , P. , Schaffer , A. A. , Kirkness , E. F. , Tanner , S. M. , de la Chapelle , A. , Giger , U. , Moestrup , S. K. , and Fyfe , J. C. ( 2005 ). Amnionless function is required for cubilin brush-border expression and intrinsic factor-cobalamin (vitamin B12) absorption in vivo . Blood 106 , 1447 – 1453 . Hennig , A. K. , Ogilvie , J. M. , Ohlemiller , K. K. , Timmers , A. M. , Hauswirth , W. W. , and Sands , M. S. ( 2004 ). AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice . Mol. Ther. 10 , 106 – 116 . Henthorn , P. S. , and Giger , U. ( 2006 ). Cystinuria . In “ The Dog and Its Genome ” ( E. A. Ostrander , U. Giger , and K. Lindblad-Toh , Eds.) , pp. 349 – 364 . Cold Spring Harbor Laboratory Press , New York . Hitte , C. , Madeoy , J. , Kirkness , E. F. , Priat , C. , Lorentzen , T. D. , Senger , F. , Thomas , D. , Derrien , T. , Ramirez , C. , Scott , C. , Evanno , G. , Pullar , B. , Cadieu , E. , Oza , V. , Lourgant , K. , Jaffe , D. B. , Tacher , S. , Dreano , S. , Berkova , N. , Andre , C. , Deloukas , P. , Fraser , C. , Lindblad-Toh , K. , Ostrander , E. A. , and Galibert , F. ( 2005 ). Facilitating genome navigation: survey sequencing and dense radiation-hybrid gene mapping . Nat. Rev. Genet. 6 ( 8 ) , 643 – 648 . Ho , T. T. , Maguire , A. M. , Aguirre , G. D. , Surace , E. M. , Anand , V. , Zeng , Y. , Salvetti , A. , Hopwood , J. J. , Haskins , M. E. , and Bennett , J. ( 2002 ). Phenotypic rescue after adeno-associated virus-mediated delivery <strong>of</strong> 4-sulfatase to the retinal pigment epithelium <strong>of</strong> feline mucopolysaccharidosis VI . J. Gene Med. 4 , 613 – 621 . Hodges , B. L. , and Cheng , S. H. ( 2006 ). Cell and gene-based therapies for the lysosomal storage diseases . Curr. Gene Ther. 6 , 227 – 241 . Hoogerbrugge , P. M. , Suzuki , K. , Suzuki , K. , Poorthuis , B. J. , Kobayashi , T. , Wagemaker , G. , and van Bekkum , D. W. (1988 ). Donor-derived cells in the central nervous system <strong>of</strong> twitcher mice after bone marrow transplantation . Science 239 , 1035 –1038 .
References 43 Johnston , J. C. , Gasmi , M. , Lim , L. E. , Elder , J. H. , Yee , J. K. , Jolly , D. J. , Campbell , K. P. , Davidson , B. L. , and Sauter , S. L. ( 1999 ). Minimum requirements for efficient transduction <strong>of</strong> dividing and nondividing cells by feline immunodeficiency virus vectors . J. Virol. 73 , 4991 – 5000 . Jung , S. C. , Han , I. P. , Limaye , A. , Xu , R. , Gelderman , M. P. , Zerfas , P. , Tirumalai , K. , Murray , G. J. , During , M. J. , Brady , R. O. , and Qasba , P. ( 2001 ). Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs <strong>of</strong> Fabry mice . Proc. Natl. Acad. Sci. USA 98 , 2676 – 2681 . Kijas , J. M. , Bauer , T. R. Jr. , Marklund , S. , Trowald-Wigh , G., Johannisson , A., Hedhammar, A., Binns, M ., Juncja , R. K., Hickstein , D . D., and Andersson , L., ( 1999 ). A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 61 , 101 – 107 . Mealey , K. L. , Bentjen , S. A. , Gay , J. M. , and Cantor , G. H. ( 2001 ). Ivermectin sensitivity in collies is associated with a deletion mutation <strong>of</strong> the mdr1 gene . Pharmacogenetics 11 , 727 – 733 . Miranda , S. R. , Erlich , S. , Friedrich , V. L. , Jr. , Gatt , S. , and Schuchman , E. H. (2000 ). Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset <strong>of</strong> neurological abnormalities in the acid sphingomyelinase deficient mouse model <strong>of</strong> Niemann- Pick disease . Gene Ther. 7 , 1768 –1776 . Miranda , S. R. , Erlich , S. , Friedrich , V. L. , Jr. , Haskins , M. E. , Gatt , S. , and Schuchman , E. H. ( 1998 ). Biochemical, pathological, and clinical response to transplantation <strong>of</strong> normal bone marrow cells into acid sphingomyelinase-deficient mice . Transplantation 65 , 884 – 892 . Nakajima , H. , Raben , N. , Hamaguchi , T. , and Yamasaki , T. ( 2002 ). Phosph<strong>of</strong>ructokinase deficiency; past, present and future . Curr. Mol. Med. 2 ( 2 ) , 197 – 212 . Neff , M. W. , Robertson , K. R. , Wong , A. K. , Safra , N. , Broman , K. W. , Slatkin , M. , Mealey , K. L. , and Pedersen , N. C. ( 2004 ). Breed distribution and history <strong>of</strong> canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence <strong>of</strong> breeds from the collie lineage . Proc. Natl. Acad. Sci. USA 101 , 11725 – 11730 . Olivier , M. , Aggarwal , A. , Allen , J. , Almendras , A. A. , Bajorek , E. S. , Beasley , E. M. , Brady , S. D. , Bushard , J. M. , Bustos , V. I. , Chu , A. , Chung , T. R. , De Witte , A. , Denys , M. E. , Dominguez , R. , Fang , N. Y. , Foster , B. D. , Freudenberg , R. W. , Hadley , D. , Hamilton , L. R. , Jeffrey , T. J. , Kelly , L. , Lazzeroni , L. , Levy , M. R. , Lewis , S. C. , Liu , X. , Lopez , F. J. , Louie , B. , Marquis , J. P. , Martinez , R. A. , Matsuura , M. K. , Misherghi , N. S. , Norton , J. A. , Olshen , A. , Perkins , S. M. , Perou , A. J. , Piercy , C. , Piercy , M. , Qin , F. , Reif , T. , Sheppard , K. , Shokoohi , V. , Smick , G. A. , Sun , W. L. , Stewart , E. A. , Fernando , J. , Tejeda , Tran , N. M. , Trejo , T. , Vo , N. T. , Yan , S. C. , Zierten , D. L. , Zhao , S. , Sachidanandam , R. , Trask , B. J. , Myers , R. M. , and Cox , D. R. (2001 ). A high-resolution radiation hybrid map <strong>of</strong> the human genome draft sequence . Science 291 ( 5507 ) , 1298 – 1302 . Olson , M. , Hood , L. , Cantor , C. , and Botstein , D. ( 1989 ). A common language for physical mapping <strong>of</strong> the human genome . Science 245 ( 4925 ) , 1434 – 1435 . Ostrander , E. A. , Giger , U. , and Lindblad-Toh , K. ( 2006 ). “ The Dog and Its Genome . ” Cold Spring Harbor Laboratory Press , New York . Passini , M. A. , Lee , E. B. , Heuer , G. G. , and Wolfe , J. H. ( 2002 ). Distribution <strong>of</strong> a lysosomal enzyme in the adult brain by axonal transport and by cells <strong>of</strong> the rostral migratory stream . J. Neurosci. 22 ( 15 ) , 6437 – 6446 . Passini , M. A. , Watson , D. J. , Vite , C. H. , Landsburg , D. J. , Feigenbaum , A. L. , and Wolfe , J. H. ( 2003 ). Intraventricular brain injection <strong>of</strong> adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns <strong>of</strong> neuronal transduction to AAV2 and total long-term correction <strong>of</strong> storage lesions in the brains <strong>of</strong> betaglucuronidase-deficient mice . J. Virol. 77 , 7034 – 7040 . Passini , M. A. , and Wolfe , J. H. ( 2001 ). Widespread gene delivery and structure-specific patterns <strong>of</strong> expression in the brain after intraventricular injections <strong>of</strong> neonatal mice with an adeno-associated virus vector . J. Virol. 75 ( 24 ) , 12382 – 12392 . Pastores , G. M. , and Barnett , N. L. ( 2005 ). Current and emerging therapies for the lysosomal storage disorders . Expert Opin. Emerg. Drugs 10 , 891 – 902 . Ponder , K. P. , Melniczek , J. R. , Xu , L. , Weil , M. A. , O’Malley , T. M. , O’Donnell , P. A. , Knox , V. W. , Aguirre , G. D. , Mazrier , H. , Ellinwood , N. M. , Sleeper , M. , Maguire , A. M. , Volk , S. W. , Mango , R. L. , Zweigle , J. , Wolfe , J. H. , and Haskins , M. E. ( 2002 ). Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs . Proc. Natl. Acad. Sci. USA 99 , 13102 – 13107 . Ponder , K. P. , Wang , B. , Wang , P. , Ma , X. , Herati , R. , Wang , B. , Cullen , K. , O’Donnell , P. , Ellinwood , N. M. , Traas , A. , Primeau , T. M. , and Haskins , M. E. ( 2006 ). Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig . Mol. Ther. 14 , 5 – 13 . Sands , M. S. , Barker , J. E. , Vogler , C. , Levy , B. , Gwynn , B. , Galvin , N. , Sly , W. S. , and Birkenmeier , E. ( 1993 ). Treatment <strong>of</strong> murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates . Lab. Invest. 68 , 676 – 686 . Sawkar , A. R. , D’Haeze , W. , and Kelly , J. W. ( 2006 ). Therapeutic strategies to ameliorate lysosomal storage disorders—a focus on Gaucher disease . Cell. Mol. Life. Sci. 63 , 1179 – 1192 . Schmidt , M. , Hacein-Bey-Abina , S. , Wissler , M. , Carlier , F. , Lim , A. , Prinz , C. , Glimm , H. , Andre-Schmutz , I. , Hue , C. , Garrigue , A. , Le Deist , F. , Lagresle , C. , Fischer , A. , Cavazzana-Calvo , M. , and von Kalle , C. (2005 ). Clonal evidence for the transduction <strong>of</strong> CD34 cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial . Blood 105 , 2699 –2706 . Schmidt , M. , Katano , H. , Bossis , I. , and Chiorini , J. A. ( 2004 ). Cloning and characterization <strong>of</strong> a bovine adeno-associated virus . J. Virol. 78 , 6509 – 6516 . Scriver , C. R. , Beaudet , A. L. , Sly , W. S., and Valle , D. ( 2001 ). “ The Metabolic and Molecular Bases <strong>of</strong> Inherited Disease , ” 8th ed . McGraw-Hill , New York . Available at www.ommbid.com Sewell , A. , Haskins , M. E. , and Giger , U. ( 2007 ). Inherited metabolic disease in companion animals: searching for nature’s mistakes . Vet. J. 174, 252–259. Shuster , D. E. , Kehrli , M. E. , Ackermann , M. R. , and Gilbert , R. O. ( 1992 ). Identification and prevalence <strong>of</strong> a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle . Proc. Natl. Acad. Sci. USA 89 , 9225 – 9229 . Skelly , B. J. , Wallace , M. , Rajpurohit , Y. , Wang , P. , and Giger , U. ( 1999 ). Identification <strong>of</strong> a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency . Am. J. Vet. Res. 60 , 1169 – 1172 . Smith , B. F. , Stedman , H. , Rajpurohit , Y. , Henthorn , P. S. , Wolfe , J. H. , Patterson , D. F. , and Giger , U. ( 1996 ). Molecular basis <strong>of</strong> canine muscle type phosph<strong>of</strong>ructokinase deficiency . J. Biol. Chem. 271 ( 33 ) , 20070 – 20074 . Stein , C. S. , and Davidson , B. L. ( 2002 ). Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors . Methods Enzymol. 346 , 433 – 454 . Stein , C. S. , Martins , I. , and Davidson , B. L. ( 2005 ). The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene
- Page 1 and 2: Preface It has been more than a dec
- Page 3 and 4: viii Contributors Björn P. Meij (5
- Page 5 and 6: 2 Chapter | 1 Concepts of Normality
- Page 7 and 8: 4 Chapter | 1 Concepts of Normality
- Page 9 and 10: 6 Chapter | 1 Concepts of Normality
- Page 11 and 12: 8 Chapter | 1 Concepts of Normality
- Page 13 and 14: 10 Chapter | 1 Concepts of Normalit
- Page 15 and 16: 12 Chapter | 1 Concepts of Normalit
- Page 17 and 18: 14 Chapter | 1 Concepts of Normalit
- Page 19 and 20: 16 Chapter | 1 Concepts of Normalit
- Page 21 and 22: 18 Chapter | 1 Concepts of Normalit
- Page 23 and 24: 20 Chapter | 1 Concepts of Normalit
- Page 25 and 26: 22 Chapter | 1 Concepts of Normalit
- Page 27 and 28: 24 Chapter | 1 Concepts of Normalit
- Page 29 and 30: Chapter 2 Comparative Medical Genet
- Page 31 and 32: I. Introduction 29 Green Red Green
- Page 33 and 34: I. Introduction 31 A1 genetic map d
- Page 35 and 36: I. Introduction 33 of genomes of va
- Page 38 and 39: 36 Chapter | 2 Comparative Medical
- Page 40 and 41: 38 Chapter | 2 Comparative Medical
- Page 42 and 43: 40 Chapter | 2 Comparative Medical
- Page 46 and 47: 44 Chapter | 2 Comparative Medical
- Page 48 and 49: 46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51: 48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53: 50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55: 52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57: 54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59: 56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61: 58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63: 60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65: 62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67: 64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69: 66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72: IX. Disorders of Carbohydrate Metab
- Page 73 and 74: IX. Disorders of Carbohydrate Metab
- Page 75 and 76: IX. Disorders of Carbohydrate Metab
- Page 77 and 78: X. Disorders of Ruminants Associate
- Page 79 and 80: X. Disorders of Ruminants Associate
- Page 81 and 82: References 79 Kaneko , J. J. , Luic
- Page 83 and 84: Chapter 4 Lipids and Ketones Michae
- Page 85 and 86: II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88: II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90: IV. Phospholipids 87 The regulation
- Page 91 and 92: V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94: VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276:
VIII. Disorders of Iron Metabolism
- Page 277 and 278:
VIII. Disorders of Iron Metabolism
- Page 279 and 280:
References 279 ( Norrdin et al ., 2
- Page 281 and 282:
References 281 Fresco , R. ( 1981 )
- Page 283 and 284:
References 283 Moore , C. V. , Duba
- Page 285 and 286:
References 285 Weiden , P. L. , Hac
- Page 287 and 288:
288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290:
290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292:
292 Chapter | 10 Hemostasis The pro
- Page 293 and 294:
294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296:
296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298:
298 Chapter | 10 Hemostasis that is
- Page 299 and 300:
300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302:
302 Chapter | 10 Hemostasis However
- Page 303 and 304:
304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306:
306 Chapter | 10 Hemostasis is a re
- Page 307 and 308:
308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310:
310 Chapter | 10 Hemostasis necessi
- Page 311 and 312:
312 Chapter | 10 Hemostasis disease
- Page 313 and 314:
314 Chapter | 10 Hemostasis concent
- Page 315 and 316:
316 Chapter | 10 Hemostasis the rol
- Page 317 and 318:
318 Chapter | 10 Hemostasis proport
- Page 319 and 320:
320 Chapter | 10 Hemostasis a consi
- Page 321 and 322:
322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324:
324 Chapter | 10 Hemostasis Dowd ,
- Page 325 and 326:
326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328:
328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330:
330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332:
332 Chapter | 11 Neutrophil Functio
- Page 333 and 334:
334 Chapter | 11 Neutrophil Functio
- Page 335 and 336:
336 Chapter | 11 Neutrophil Functio
- Page 337 and 338:
338 Chapter | 11 Neutrophil Functio
- Page 339 and 340:
340 Chapter | 11 Neutrophil Functio
- Page 341 and 342:
342 Chapter | 11 Neutrophil Functio
- Page 343 and 344:
344 Chapter | 11 Neutrophil Functio
- Page 345 and 346:
346 Chapter | 11 Neutrophil Functio
- Page 347 and 348:
348 Chapter | 11 Neutrophil Functio
- Page 349 and 350:
350 Chapter | 11 Neutrophil Functio
- Page 351 and 352:
352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354:
354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356:
356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358:
358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360:
360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362:
362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364:
364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366:
366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368:
368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370:
370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372:
372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464:
III. Heterogeneity of Skeletal Musc
- Page 465 and 466:
III. Heterogeneity of Skeletal Musc
- Page 467 and 468:
V. Exercise and Adaptations to Trai
- Page 469 and 470:
VI. Diagnostic Laboratory Methods f
- Page 471 and 472:
VI. Diagnostic Laboratory Methods f
- Page 473 and 474:
IX. Selected Neuromuscular Disorder
- Page 475 and 476:
IX. Selected Neuromuscular Disorder
- Page 477 and 478:
References 479 and, recently, there
- Page 479 and 480:
References 481 Engel , A. G. ( 2004
- Page 481 and 482:
References 483 Paciello , O. , Maio
- Page 483 and 484:
Chapter 16 Kidney Function and Dama
- Page 485 and 486:
II. Kidney Morphology and Function
- Page 487 and 488:
II. Kidney Morphology and Function
- Page 489 and 490:
III. Tests of Kidney Function 491 (
- Page 491 and 492:
III. Tests of Kidney Function 493 T
- Page 493 and 494:
III. Tests of Kidney Function 495 B
- Page 495 and 496:
6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498:
III. Tests of Kidney Function 499 d
- Page 499 and 500:
IV. Tests of Kidney Damage 501 1000
- Page 501 and 502:
IV. Tests of Kidney Damage 503 and
- Page 503 and 504:
IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506:
V. Biochemical Changes in Kidney Di
- Page 507 and 508:
V. Biochemical Changes in Kidney Di
- Page 509 and 510:
References 511 were reported to occ
- Page 511 and 512:
References 513 Bovee , K. C. ( 1969
- Page 513 and 514:
References 515 Deguchi , E. , and A
- Page 515 and 516:
References 517 Fleming , S. A. , Hu
- Page 517 and 518:
References 519 Harvey , D. G. ( 197
- Page 519 and 520:
References 521 Kühl , S. , Mischke
- Page 521 and 522:
References 523 creatinine measureme
- Page 523 and 524:
References 525 Reusch , C. , Vochez
- Page 525 and 526:
References 527 Terry , R. , Hawkins
- Page 527 and 528:
Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531:
532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535:
536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537:
538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539:
540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541:
542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543:
544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545:
546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547:
548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549:
550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552:
VIII. Clinicopathological Indicator
- Page 553 and 554:
References 555 plasma water, electr
- Page 555 and 556:
References 557 Krzywanek , H. ( 197
- Page 557 and 558:
References 559 Strombeck , D. R. (1
- Page 559 and 560:
562 Chapter | 18 Pituitary Function
- Page 561 and 562:
564 Chapter | 18 Pituitary Function
- Page 563 and 564:
566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl